Science of DME Newsfeed Archived News
(English) FDA Grants Priority Review of Antiangiogenic Agent Aflibercept for Treatment of Diabetic Retinopathy in DME Patients
Ci spiace, ma questo articolo è disponibile soltanto in English.
Choose Language
Connect and Share
Color:
Font size:
